US Broker Ratings

Nutex Health Inc. (NUTX) Investor Outlook: 111% Potential Upside in Healthcare Innovator

Nutex Health Inc. (NUTX), a healthcare services and operations company, has caught the attention of investors with its impressive growth trajectory and significant potential upside. Based in Houston, Texas, Nutex..

Sionna Therapeutics, Inc. (SION): Analyst Ratings Signal an 83.86% Upside for Biotech Innovators

Sionna Therapeutics, Inc. (SION), a burgeoning name in the biotechnology sector, has captured the attention of investors with its promising therapeutic developments and remarkable analyst ratings. With a market capitalization..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: A Biotech Gem with 139% Upside Potential

Nurix Therapeutics, Inc. (NASDAQ: NRIX) stands out in the biotechnology sector, offering investors a compelling opportunity with a significant potential upside of 139.41%. Despite the company’s current challenges, which are..

Arbutus Biopharma (ABUS) Stock Analysis: 62% Potential Upside Amid Biotech Innovation

Arbutus Biopharma Corporation (NASDAQ: ABUS) is garnering attention from investors keen on biotechnological advancements in healthcare. With a market capitalization of $628.21 million, Arbutus Biopharma stands out as a clinical-stage..

Dianthus Therapeutics, Inc. (DNTH) Stock Analysis: Biotechnology Marvel with a 149% Potential Upside

Dianthus Therapeutics, Inc. (NASDAQ: DNTH), a promising player in the biotechnology sector, is capturing investor attention with its innovative approach to treating severe autoimmune and inflammatory diseases. With a market..

Evolus, Inc. (EOLS) Stock Analysis: Unveiling a 142% Potential Upside with Strong Buy Ratings

Evolus, Inc. (NASDAQ: EOLS), a burgeoning name in the healthcare sector, has been catching the eyes of investors with its promising growth potential. Specializing in the aesthetic pharmaceutical market, Evolus..

Beta Bionics, Inc. (BBNX) Stock Analysis: Navigating a 73.71% Potential Upside in the Growing Medical Devices Market

Beta Bionics, Inc. (NASDAQ: BBNX) stands as a compelling investment opportunity within the healthcare sector, specifically in the innovative realm of medical devices. With a market capitalization of $600.31 million,..

CeriBell, Inc. (CBLL) Stock Analysis: Exploring an 83.97% Upside Potential in the Medical Device Sector

CeriBell, Inc. (CBLL) is making waves in the healthcare sector, specifically within the medical devices industry, as it continues to push the boundaries of neurological diagnostics with its innovative Ceribell..

Embecta Corp. (EMBC) Stock Analysis: Analyzing a 73.97% Potential Upside in the Healthcare Sector

Embecta Corp. (NASDAQ: EMBC), a longstanding player in the medical instruments and supplies industry, is capturing investor attention with a striking potential upside of 73.97%. As a company dedicated to..

RxSight, Inc. (RXST) Stock Analysis: Eye-Catching Potential with 150% Upside

RxSight, Inc. (RXST), a trailblazer in the healthcare sector’s medical devices industry, is making waves with its innovative technology and substantial growth potential. With a market capitalization of $365.84 million,..

AnaptysBio, Inc. (ANAB) Stock Analysis: Unpacking a 63% Potential Upside in the Biotech Sector

AnaptysBio, Inc. (NASDAQ: ANAB) has emerged as a compelling player in the biotechnology sector, capturing the attention of investors with its robust pipeline of immunology therapeutics. With a current market..

Phibro Animal Health Corporation (PAHC): Analyst Ratings Signal a -24.53% Downside – What Investors Need to Know

Phibro Animal Health Corporation (NASDAQ: PAHC) is a notable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $1.25 billion,..

Zymeworks Inc. (ZYME) Stock Analysis: Unveiling a 57.80% Potential Upside with Innovative Biotech Advancements

Zymeworks Inc. (NASDAQ: ZYME), a clinical-stage biotechnology company headquartered in Middletown, Delaware, has been making waves in the healthcare sector with its focus on innovative biotherapeutics for cancer and autoimmune..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: Unveiling a 195% Upside Potential in the Biotech Sector

Arcus Biosciences, Inc. (NASDAQ: RCUS), a clinical-stage biopharmaceutical company, is capturing investor attention with a compelling potential upside of 195.41%. This makes it an intriguing opportunity for those interested in..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: Exploring a 94% Potential Upside

Investors with an eye on the healthcare sector, particularly within the biotechnology industry, might find Praxis Precision Medicines, Inc (NASDAQ: PRAX) an intriguing proposition. With a focus on developing therapies..

Avadel Pharmaceuticals plc (AVDL) Stock Analysis: Exploring a 69.62% Potential Upside in the Biopharmaceutical Sector

Avadel Pharmaceuticals plc (NASDAQ: AVDL) is a compelling player in the biopharmaceutical industry, offering investors a noteworthy opportunity for growth. With its market cap standing at approximately $968.53 million, Avadel..

Weave Communications, Inc. (WEAV): Investor Outlook on its 68.17% Potential Upside

For those seeking lucrative opportunities in the health information services sector, Weave Communications, Inc. (NASDAQ: WEAV) presents an intriguing proposition. With a market capitalization of $632.28 million, this Lehi, Utah-based..

Simulations Plus, Inc. (SLP) Stock Analysis: Exploring a Potential 106% Upside in Health Information Services

Simulations Plus, Inc. (NASDAQ: SLP), a leading player in the healthcare sector, is making waves with its innovative software solutions designed for drug discovery and development. With a market capitalization..

InMode Ltd. (INMD) Stock Analysis: Unlocking a 12.32% Upside Potential in the Aesthetic Medical Device Sector

InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector focusing on medical devices, offers intriguing opportunities for investors seeking exposure to the minimally invasive aesthetic medical products market...

AMN Healthcare Services Inc (AMN) Stock Analysis: Evaluating a 20% Potential Upside Amidst Market Challenges

As investors navigate the dynamic landscape of the healthcare sector, AMN Healthcare Services Inc (NYSE: AMN) presents an intriguing opportunity with its diverse service offerings and notable market positioning. Based..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds